case_images: PMC6581023_01
case_images: Plasma glucose during treatment with atezolizumab.
case_images: fendo-10-00352-g0001.jpg
case_images: PMC6581023_01_fendo-10-00352-g0001.jpg
case_images: F1
case_images: Her fasting plasma glucose was 85 mg/dL (4.7 mmol/L) before atezolizumab initiation (plasma glucose levels during therapy are shown in Figure 1).